These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 8596121

  • 1. Effects of sub-minimal inhibitory concentrations of antimicrobial agents on the cell surface of Klebsiella pneumoniae and phagocytic killing activity.
    Nomura S, Murata K, Nagayama A.
    J Chemother; 1995 Oct; 7(5):406-13. PubMed ID: 8596121
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
    Nomura S, Nagayama A.
    Chemotherapy; 1995 Oct; 41(4):267-75. PubMed ID: 7555207
    [Abstract] [Full Text] [Related]

  • 3. Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones.
    Hostacká A.
    Microbios; 1997 Oct; 91(368-369):137-43. PubMed ID: 9523422
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin and amikacin.
    Hostacká A.
    J Basic Microbiol; 1998 Oct; 38(5-6):383-8. PubMed ID: 9871334
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ASK2 Bioactive Compound Inhibits MDR Klebsiella pneumoniae by Antibiofilm Activity, Modulating Macrophage Cytokines and Opsonophagocytosis.
    Lalitha C, Raman T, Rathore SS, Ramar M, Munusamy A, Ramakrishnan J.
    Front Cell Infect Microbiol; 2017 Oct; 7():346. PubMed ID: 28824881
    [Abstract] [Full Text] [Related]

  • 10. [Aminoglycosides and colistin inhibit biofilm formation in Klebsiella pneumoniae].
    Hostacká A, Ciznár I.
    Epidemiol Mikrobiol Imunol; 2008 Aug; 57(3):101-5. PubMed ID: 18767377
    [Abstract] [Full Text] [Related]

  • 11. The influence of the O and K antigens of Klebsiella aerogenes on surface hydrophobicity and susceptibility to phagocytosis and antimicrobial agents.
    Williams P, Lambert PA, Haigh CG, Brown MR.
    J Med Microbiol; 1986 Mar; 21(2):125-32. PubMed ID: 2419562
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
    Nomura S, Nagayama A.
    Chemotherapy; 1995 Mar; 41(3):178-86. PubMed ID: 7656663
    [Abstract] [Full Text] [Related]

  • 13. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.
    Huang SR, Liu MF, Lin CF, Shi ZY.
    J Microbiol Immunol Infect; 2014 Jun; 47(3):187-96. PubMed ID: 23200553
    [Abstract] [Full Text] [Related]

  • 14. Pefloxacin and immunity: cellular uptake, potentiation of macrophage phagocytosis and intracellular bioactivity for Klebsiella pneumoniae.
    Cuffini AM, Tullio V, Fazari S, Allocco A, Carlone NA.
    Int J Tissue React; 1992 Jun; 14(3):131-9. PubMed ID: 1446977
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z, Kayacan C, Oncul O.
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
    Landman D, Singh M, El-Imad B, Miller E, Win T, Quale J.
    Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
    Cuffini AM, De Renzi G, Tullio V, Paizis G, Carlone NA.
    Drugs Exp Clin Res; 1996 Jun; 22(1):9-15. PubMed ID: 8839632
    [Abstract] [Full Text] [Related]

  • 18. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
    Sho T, Muratani T, Hamasuna R, Yakushiji H, Fujimoto N, Matsumoto T.
    Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.